We report the pro-leukemic activities of PRMT5 in AML partly via modulating the transcription of key genes. The goal of this experiment is to confirm the changes observed in expression of genes targeted by PRMT5 activities. RNA Deep sequencing was employed to validate and reproduce the changes measured by quantitative reverse transcription polymerase chain reaction (qRTPCR) techniques. SOURCE: Xiwei Wu (xwu@coh.org) - Integrative Genomics Core Beckman Research Institute

Pluto Bioinformatics

GSE75215: RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells